Recent Updates
Recently added Catalysts
ZLAB Positive Sentiment

Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023

Key Takeaway: Zai Lab Limited will report its third quarter 2023 financial results on November 7, 2023, after market close. A conference call and webcast will follow on November 8, 2023, at 8:00 a.m. ET. The event will provide insights into the company's recent corporate updates and financial performance.
Price reaction · baseline $23.91 (2023-10-20 close) · 1 other ZLAB headline(s) in the window, move may be shared
day 0 close
+0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Zai Lab is set to announce its Q3 2023 financial results, indicating ongoing operations.
  • The company is focused on innovative biopharmaceutical development, addressing unmet medical needs.
  • The scheduled conference call allows for direct communication with investors and stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+104%
120-day peak, hindsight
Typical move
8.5%
average across 4 past catalysts
Cash runway
~164 mo
Low dilution risk
Lead asset
ZL-1211
Phase 1 · Advanced Solid Tumor

Full Press Release Details

• Company to Host Conference Call and Webcast on November 8, 2023, at 8:00 a.m. ET SHANGHAI, China and CAMBRIDGE, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the third quarter of 2023 and recent corporate updates, after the closing of the U.S. equity markets on November 7, 2023. The Company will host a live conference call and webcast on November 8, 2023, at 8:00 a.m. ET. Conference Call and Webcast Information Listeners may access the live webcast by visiting the Company’s website at http://ir.zailaboratory.com. Participants must register in advance of the conference call. Details are as follows: Registration Link: https://register.vevent.com/register/BI87a7a83f6a6441279fddbaae217dd092 All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-in details will be in the confirmation email which the participant will receive upon registering. A replay will be available shortly after the call and can be accessed by visiting the Company’s website. About Zai Lab Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide. For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global. For more information, please contact: Investor Relations: Christine Chiou / Lina Zhang+1 (917) 886-6929 / +86 136 8257 6943christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com Media: Shaun Maccoun / Xiaoyu Chen+1 (415) 317-7255 / +86 185 0015 5011shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com Source: Zai Lab Limited
Source: Zai Lab Limited

Frequently Asked Questions

When will Zai Lab announce its Q3 2023 financial results?

Zai Lab will announce its Q3 2023 financial results on November 7, 2023.

What time is the Zai Lab conference call?

The conference call will take place on November 8, 2023, at 8:00 a.m. ET.

How can I access the Zai Lab conference call?

Listeners can access the call by registering through the provided link on Zai Lab's website.

What is Zai Lab's focus in biopharmaceuticals?

Zai Lab focuses on developing innovative products for oncology, autoimmune disorders, infectious diseases, and neuroscience.

Last updated: Oct 21, 2023